advancing innovation to save lives

The Hill features op-ed from GHTC director

The Hill featured an op-ed from GHTC Director Jamie Bay Nishi which highlights the historic decline in US government investment in neglected disease R&D and calls for the US to increase funding and reassert American leadership in global health innovation.

Pipeline of Promise

Learn about the global health R&D process through our interactive Pipeline of Promise infographic.
Learn More

International Partnership For Microbicides

The International Partnerships for Microbicides (IPM) is a nonprofit organization that developed the monthly dapivirine ring, and is dedicated to accelerating the development and availability of other new HIV prevention tools for women in developing countries.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
GHTC, GHC, PATH, American Academy of Pediatrics
GHTC delivers statement on antimicrobial resistance at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) welcoming global political commitments to combat antimicrobial drug resistance (AMR) and calling for these efforts to prioritize R&D for new tools. The statement, which was issued in partnership with the Global Health Council, PATH, and the American Academy of Pediatrics, also welcomes the establishment of the Global Antimicrobial Surveillance System and urges WHO to monitor progress by member states in implementing national AMR actions plans to promote accountability.

GHTC delivers statement on R&D for epidemic disease at WHA

GHTC delivered a statement at the 70th World Health Assembly (WHA) highlighting the critical role new tools play in epidemic preparedness. The statement, issued in partnership with the Global Health Council and PATH, calls on the World Health Organization and member states to support regulatory capacity building and harmonization efforts, as well as coordinated approaches to develop new technologies through entities like the Coalition for Epidemic Preparedness.

View All News & Events

Community Event

McGill University
McGill Summer Institute in Infectious Diseases and Global Health
McGill University
Learn More
View All Events
Photo: White house/Shealah Craighead
Medical research, global health programs face steep cuts in Trump budget

On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.

Read More
CDC/Dr. Scott Smith
G20 health ministers pledge support for R&D to combat antimicrobial resistance, pandemic threats

Health ministers from G20 nations, meeting for the first time, pledged to work together to combat antimicrobial resistance and improve pandemic preparedness, emphasizing the critical role research and development plays in confronting these global challenges.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide